Institutions / Braidwell LP

Braidwell LP

CIK 1920938 · Institution · as of Dec 31, 2025
Portfolio value
$3.13B
Positions
73
As of
Dec 31, 2025

Top holdings

Dec 31, 2025View all 73 →
CompanyClassValueShares% of portfolio
Caris Life Sciences, Inc.$210.88M7,816,1426.7%
Guardant Health Inc$192.31M104,854,0006.2%
Edgewise Therapeutics, Inc.$129.31M5,210,8314.1%
Repligen Corp$110.85M101,000,0003.5%
Neurocrine Biosciences Inc$106.59M751,5343.4%
Glaukos Corp$104.10M921,9793.3%
Neogenomics Inc$89.72M100,381,0002.9%
Nuvalent, Inc.$82.63M821,4062.6%
Xenon Pharmaceuticals Inc.$81.80M1,825,0762.6%
CG Oncology, Inc.$77.67M1,870,5712.5%
Irhythm Technologies Inc$72.80M52,000,0002.3%
Hinge Health, Inc.$60.60M1,304,6231.9%
Align Technology, Inc.$59.49M381,0041.9%
Kodiak Sciences Inc.KODCommon Stock$57.96M2,072,7881.9%
Soleno Therapeutics, Inc.$55.00M1,187,8591.8%
Centessa Pharmaceuticals PLC$54.73M2,188,3201.8%
NeoGenomics Inc$54.48M4,632,8011.7%
ACADIA Pharmaceuticals Inc$54.28M2,032,0211.7%
Spyre Therapeutics, Inc.$53.55M1,634,6151.7%
Dianthus Therapeutics, Inc.$52.50M1,273,9351.7%
Ironwood Pharmaceuticals Inc$50.47M53,405,0001.6%
Celldex Therapeutics, Inc.$50.47M1,858,1091.6%
Inspire Medical Systems, Inc.$49.89M540,8901.6%
Krystal Biotech, Inc.$49.83M202,1011.6%
Intuitive Surgical Inc$47.24M83,4171.5%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.